ZEMPLAR Side Effects

7023415-4 | Adverse Event, Dyspnoea
on Sep 23, 2010 Male patient from UNITED STATES , weighting 123.5 lb, was diagnosed with renal failure chronic and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, dyspnoea. Zemplar dosage: . Patient was hospitalized.

7023255-6 | Gastric Haemorrhage, Melaena
Patient was taking Zemplar (View Usage). Patient had the following side effects: gastric haemorrhage, melaena on Sep 22, 2010 from GREECE Additional patient health information: Male patient , 81 years of age, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary, arthralgia, arteriosclerosis, hyperphosphataemia, anaemia and. Zemplar dosage: . During the same period patient was treated with XEFO (View Xefo Review and Xefo Label ), VASTAREL (View Vastarel Review and Vastarel Label ), FORSENOL (750mg At Noon And 750mg In The Evening) (View Forsenol Review and Forsenol Label ), FILICINE (View Filicine Review and Filicine Label ), RENAGEL (3 Caps In Am, 3 At Noon And 3 In Pm) (View Renagel Review and Renagel Label ). Patient was hospitalized.

7023254-4 | Cardiac Arrest
Adverse event was reported on Sep 27, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 221.2 lb, After Zemplar was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?).

7022328-1 | Bacteraemia, Cardiac Disorder, Hypertension, Pain, Renal Failure
on Sep 21, 2010 Male patient from UNITED STATES , weighting 140.1 lb, was diagnosed with renal failure, hyperparathyroidism secondary, cardiac disorder, pain (What is pain?), mineral supplementation and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, cardiac disorder, hypertension, pain (What is pain?), renal failure. Zemplar dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DARVOCET (View Darvocet Review and Darvocet Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), HEMAX (View Hemax Review and Hemax Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.


7022297-4 | Confusional State
on Sep 21, 2010 Male patient from HUNGARY , weighting 141.1 lb, was diagnosed with hyperparathyroidism secondary, hypertension and was treated with Zemplar (View Usage). Patient had the following side effects: confusional state. Zemplar dosage: 5ug/1ml/ampule, 3 Ampules/dialysis. During the same period patient was treated with ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), CALCII CARBONICI (View Calcii Carbonici Review and Calcii Carbonici Label ), KETOSTERIL (View Ketosteril Review and Ketosteril Label ), CO PRENESSA (4mg/1.25mg Daily) (View Co-prenessa Review and Co-prenessa Label ). Patient was hospitalized.

7021028-1 | Subclavian Artery Stenosis, Vascular Pseudoaneurysm
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: subclavian artery stenosis, vascular pseudoaneurysm on Sep 20, 2010 from GERMANY Additional patient health information: Female patient , 56 years of age, weighting 134.5 lb, was diagnosed with hyperparathyroidism secondary and. Zemplar dosage: 28 Mcg Weekly. During the same period patient was treated with CHOLECALCIFEROL (1000 Ie Per Week) (View Cholecalciferol Review and Cholecalciferol Label ), NIMPARA (630 Mg Per Week) (View Nimpara Review and Nimpara Label ), RENAGEL (4800 Mg) (View Renagel Review and Renagel Label ), ERYPO (12000ie Per Week) (View Erypo Review and Erypo Label ), FALITHROM (View Falithrom Review and Falithrom Label ), DREISAVIT (View Dreisavit Review and Dreisavit Label ), VIGANTOLETTEN (View Vigantoletten Review and Vigantoletten Label ), BICANORM (View Bicanorm Review and Bicanorm Label ). Patient was hospitalized.

7021022-0 | Aortic Stenosis, Atrial Fibrillation, Dialysis, Renal Failure
Adverse event was reported on Sep 27, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 180.2 lb, Patient experienced the following unwanted or unexpected effects: aortic stenosis, atrial fibrillation (What is atrial fibrillation?), dialysis (What is dialysis?), renal failure. During the same period patient was treated with HUMALOG MIX 75/25 (View Humalog Mix 75/25 Review and Humalog Mix 75/25 Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PROBENACID (View Probenacid Review and Probenacid Label ), PREVACID (View Prevacid Review and Prevacid Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), RENAGEL (View Renagel Review and Renagel Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ).

7018862-0 | Dysarthria, Gait Disturbance, Hypophagia, Renal Failure Chronic
on Sep 23, 2010 Female patient from UNITED STATES , weighting 98.09 lb, was diagnosed with renal failure, insomnia, pain (What is pain?) and was treated with Zemplar (View Usage). Patient had the following side effects: dysarthria, gait disturbance, hypophagia, renal failure chronic. Zemplar dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SINEQUAN (View Sinequan Review and Sinequan Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ). Patient was hospitalized.

7018548-2 | Blood Creatinine Increased, Blood Urea Increased, Cardiac Arrest, Cardio-respiratory Arrest, Cerebrovascular Accident, Confusional State, Diabetic Coma, Dyspnoea, Haematocrit Decreased
on Sep 23, 2010 Male patient from UNITED STATES , weighting 272.2 lb, was diagnosed with hypertension, diabetes mellitus and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: blood creatinine increased, blood urea increased, cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, cerebrovascular accident, confusional state, diabetic coma, dyspnoea, haematocrit decreased. Zemplar dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LASIX (View Lasix Review and Lasix Label ), CLONIDINE HCL (View Clonidine Hcl Review and Clonidine Hcl Label ), LANTUS (View Lantus Review and Lantus Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7016828-8 | Arteriosclerosis Obliterans, Erythema, Gastrointestinal Haemorrhage, Hyperphosphataemia, Leg Amputation, Oedema Peripheral, Pain In Extremity, Peripheral Arterial Occlusive Disease, Pulse Absent
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis obliterans, erythema, gastrointestinal haemorrhage, hyperphosphataemia, leg amputation, oedema peripheral, pain in extremity, peripheral arterial occlusive disease, pulse absent on Sep 17, 2010 from GERMANY Additional patient health information: Female patient , weighting 202.8 lb, was diagnosed with hyperparathyroidism secondary, hypertension, polyuria, pain (What is pain?), restless legs syndrome and. Zemplar dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), TORASEMID (View Torasemid Review and Torasemid Label ), OSVAREN (View Osvaren Review and Osvaren Label ), DREISAVIT N (View Dreisavit N Review and Dreisavit N Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), FENTANYL PLASTER (Per Hour Every Three Days) (View Fentanyl Plaster Review and Fentanyl Plaster Label ), RESTEX (On Demand) (View Restex Review and Restex Label ). Patient was hospitalized.

7012074-2 | Dilatation Atrial, Hypertensive Crisis, Pericardial Effusion, Sinus Tachycardia
Adverse event was reported on Sep 14, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary, hypertension, gastritis and. Location: AUSTRIA , 28 years of age, weighting 87.96 lb, Patient had the following side effects: dilatation atrial, hypertensive crisis, pericardial effusion, sinus tachycardia. During the same period patient was treated with RENAGEL (2-2-2) (View Renagel Review and Renagel Label ), DIOVAN (1-0-1) (View Diovan Review and Diovan Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), PANTOLOC (View Pantoloc Review and Pantoloc Label ). Patient was hospitalized.

7006394-5 | Gastric Haemorrhage, Melaena
on Sep 13, 2010 Male patient from GREECE , 81 years of age, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary, arthralgia, arteriosclerosis, hyperphosphataemia, anaemia and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: gastric haemorrhage, melaena. Zemplar dosage: . During the same period patient was treated with XEFO (View Xefo Review and Xefo Label ), VASTAREL (View Vastarel Review and Vastarel Label ), FORSENOL (750mg At Noon And 750mg In The Evening) (View Forsenol Review and Forsenol Label ), FILICINE (View Filicine Review and Filicine Label ), RENAGEL (3 Caps In Am, 3 At Noon And 3 In Pm) (View Renagel Review and Renagel Label ). Patient was hospitalized.

7003507-6 | Confusional State
on Sep 16, 2010 Male patient from HUNGARY , weighting 141.1 lb, was diagnosed with hyperparathyroidism secondary, hypertension and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state. Zemplar dosage: 5ug/1ml/ampule, 3 Ampules/dialysis. During the same period patient was treated with ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), CALCII CARBONICI (View Calcii Carbonici Review and Calcii Carbonici Label ), KETOSTERIL (View Ketosteril Review and Ketosteril Label ), CO PRENESSA (4mg/1.25mg Daily) (View Co-prenessa Review and Co-prenessa Label ). Patient was hospitalized.

7003506-4 | Confusional State, Hypertension
Patient was taking Zemplar (View Usage). Patient had the following side effects: confusional state, hypertension on Sep 16, 2010 from HUNGARY Additional patient health information: Female patient , weighting 231.5 lb, was diagnosed with hyperparathyroidism secondary and. Zemplar dosage: 5ug/1ml/ampule, 4 Ampule/dialysis. During the same period patient was treated with CINACALCET HYDROCHLORIDE (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ). Patient was hospitalized.

6986016-X | Pulmonary Embolism
Adverse event was reported on Sep 09, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: ) . Location: GERMANY , 85 years of age, After Zemplar was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

6977537-4 | Arteriosclerosis, Arteriosclerosis Coronary Artery, Blood Calcium Increased, Blood Pressure Decreased, Bradycardia, Cardiac Tamponade, Circulatory Collapse, Coronary Artery Disease, Coronary Artery Occlusion
on Aug 31, 2010 Male patient from GERMANY , weighting 195.1 lb, was diagnosed with hyperparathyroidism secondary, blood parathyroid hormone increased and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, arteriosclerosis coronary artery, blood calcium increased, blood pressure decreased, bradycardia, cardiac tamponade, circulatory collapse, coronary artery disease (What is coronary artery disease?), coronary artery occlusion. Zemplar dosage: 1 Ampoule 5 Mcg/ml Injection Amp I.v.. During the same period patient was treated with FOSRENOL (1000mg Chewing Tablets At Meal Time :tid/daily Dose 2000mg) (View Fosrenol Review and Fosrenol Label ), BLOPRESS (16mg Tablets Bid/daily Dose 24mg) (View Blopress Review and Blopress Label ), VESDIL PROTECT (10mg Tablets/bid Daily Dose 15mg) (View Vesdil Protect Review and Vesdil Protect Label ), MOXONIDIN AL (0.3mg Tablets Qid Daily Dose 0.9mg) (View Moxonidin Al Review and Moxonidin Al Label ), CARMEN (20mg Tablets Bid 30mg) (View Carmen Review and Carmen Label ), CONCOR (5 Tablets Bid) (View Concor Review and Concor Label ), EBRANTIL (30 Retard Capsules Bid) (View Ebrantil Review and Ebrantil Label ). Patient was hospitalized.

6977459-9 | Renal Transplant
on Sep 01, 2010 Male patient from GERMANY , 50 years of age, weighting 159.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). Patient had the following side effects: renal transplant. Zemplar dosage: 10 Mcg Per Week. During the same period patient was treated with FERRLECIT (View Ferrlecit Review and Ferrlecit Label ), FOLGAMMA (View Folgamma Review and Folgamma Label ), EXFORGE (10 Mg/160 Mg Od) (View Exforge Review and Exforge Label ), MINIASAL (View Miniasal Review and Miniasal Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), DECOSTRIOL (View Decostriol Review and Decostriol Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ANTIPHOSPHAT (View Antiphosphat Review and Antiphosphat Label ). Patient was hospitalized.

6977399-5 | Cardiac Failure, Cardio-respiratory Arrest, Fall, Fluid Retention, Insomnia, Pain, Renal Failure
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: cardiac failure, cardio-respiratory arrest, fall (What is fall?), fluid retention, insomnia, pain (What is pain?), renal failure on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 173.2 lb, was diagnosed with renal failure, chronic obstructive pulmonary disease, diabetes mellitus, anaemia and. Zemplar dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (2 In 1 Days, As Needed) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), INSULIN (Daily) (View Insulin Review and Insulin Label ), LASIX (View Lasix Review and Lasix Label ), DEMADEX (View Demadex Review and Demadex Label ), SUPPLEMENTS (View Supplements Review and Supplements Label ), IRON (View Iron Review and Iron Label ).

6977206-0 | Iiird Nerve Paresis, Polyneuropathy
Adverse event was reported on Aug 30, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: 5 Mcg Per Week) was diagnosed with hyperparathyroidism secondary and. Location: GERMANY , 75 years of age, weighting 188.5 lb, Patient experienced the following unwanted or unexpected effects: iiird nerve paresis, polyneuropathy. Patient was hospitalized.

6976903-0 | Cardiac Failure, Hypertension, Implantable Defibrillator Insertion
on Aug 31, 2010 Male patient from GERMANY , weighting 173.1 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease (What is coronary artery disease?), blood phosphorus increased, peripheral arterial occlusive disease and was treated with Zemplar (View Usage). Patient had the following side effects: cardiac failure, hypertension, implantable defibrillator insertion. Zemplar dosage: . During the same period patient was treated with ISMO (View Ismo Review and Ismo Label ), ANTRAMUPS (View Antramups Review and Antramups Label ), ANTIPHOSPHATE (View Antiphosphate Review and Antiphosphate Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6973895-5 | Cardiovascular Disorder, Catheterisation Cardiac, Coronary Arterial Stent Insertion, Diarrhoea, Dyspnoea, Extremity Necrosis, Ischaemia, Medical Device Complication, Peritonitis
on Aug 30, 2010 Male patient from GERMANY , 76 years of age, weighting 180.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: cardiovascular disorder, catheterisation cardiac, coronary arterial stent insertion, diarrhoea, dyspnoea, extremity necrosis, ischaemia, medical device complication, peritonitis. Zemplar dosage: . During the same period patient was treated with PHOSEX (View Phosex Review and Phosex Label ), ARANESP (View Aranesp Review and Aranesp Label ), DIOVAN (View Diovan Review and Diovan Label ), PATZOL (View Patzol Review and Patzol Label ), MARCUMAR (According To Quick) (View Marcumar Review and Marcumar Label ), CARBIMAZOL (View Carbimazol Review and Carbimazol Label ), KALINOR RETARD P (View Kalinor-retard P Review and Kalinor-retard P Label ). Patient was hospitalized and became disabled.

6973534-3 | Transplant
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: transplant on Sep 01, 2010 from GERMANY Additional patient health information: Female patient , 54 years of age, weighting 132.3 lb, was diagnosed with hyperparathyroidism secondary and. Zemplar dosage: . During the same period patient was treated with DEKRISTOL (20000 Ie) (View Dekristol Review and Dekristol Label ), RENAGEL (Am 1 Tablet, Noon 2; Evening 2) (View Renagel Review and Renagel Label ), CALCET (Noon, Evening) (View Calcet Review and Calcet Label ), ARANESP (One Pre Filled Syrige Every Other Week) (View Aranesp Review and Aranesp Label ), ALLOPURINOL HEXAL (Opd, 1/2 Tablet In Evening) (View Allopurinol Hexal Review and Allopurinol Hexal Label ), DREISAVIT N (Opd, Morning) (View Dreisavit N Review and Dreisavit N Label ), NOVALGIN (If Required) (View Novalgin Review and Novalgin Label ). Patient was hospitalized.

6968570-7 | Cardiac Failure, Diabetic Foot, Dyspnoea, Hypertensive Heart Disease, Oedema Peripheral, Orthopnoea
Adverse event was reported on Aug 28, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary, cardiac failure, hyperphosphataemia, zinc deficiency, arthralgia, type 1 diabetes mellitus and. Location: GERMANY , weighting 264.6 lb, Patient had the following side effects: cardiac failure, diabetic foot, dyspnoea, hypertensive heart disease, oedema peripheral, orthopnoea. During the same period patient was treated with TORASEMID (Bid: Tue,thur,sun. 1-0-1: Mon,wed,fri. 0-1-1sat.) (View Torasemid Review and Torasemid Label ), CONCOR COR (In Morning And Evening) (View Concor Cor Review and Concor Cor Label ), ASS RATIOPHARM (In Morning, Opd) (View Ass Ratiopharm Review and Ass Ratiopharm Label ), OSVAREN (In Morning And Evening) (View Osvaren Review and Osvaren Label ), ZINKIT (In Evening) (View Zinkit Review and Zinkit Label ), LYRICA (In Evening) (View Lyrica Review and Lyrica Label ), LEVEMIR (According To Plan: 44 Iu - 0 - 30iu - 0) (View Levemir Review and Levemir Label ), NOVORAPID (According To Blood Glucose) (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6966275-X | Cardiac Failure, Congestive Cardiomyopathy, Hypertensive Heart Disease, Lung Infiltration
on Aug 30, 2010 Male patient from GERMANY , 46 years of age, weighting 224.9 lb, was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: cardiac failure, congestive cardiomyopathy, hypertensive heart disease, lung infiltration. Zemplar dosage: . During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), CALCIUMACETAT (View Calciumacetat Review and Calciumacetat Label ), CHOLECALCIFEROL (7000ie) (View Cholecalciferol Review and Cholecalciferol Label ), ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ). Patient was hospitalized.

6966272-4 | Venous Thrombosis
on Aug 24, 2010 Female patient from GERMANY , 66 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease (What is coronary artery disease?) and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: venous thrombosis. Zemplar dosage: . During the same period patient was treated with ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), CALCIUMACETAT (View Calciumacetat Review and Calciumacetat Label ), RENAGEL (View Renagel Review and Renagel Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FOSINORM (View Fosinorm Review and Fosinorm Label ), EXFORGE (10 Mg/ 160 Mg, Daily) (View Exforge Review and Exforge Label ), RASILEZ (View Rasilez Review and Rasilez Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ). Patient was hospitalized.

6965886-5 |
Patient was taking Zemplar (View Usage). on Aug 30, 2010 from GERMANY Additional patient health information: Male patient , 71 years of age, weighting 198.4 lb, . Zemplar dosage: 15 Mg Per Week. During the same period patient was treated with ERYPO (20000ie Per Week) (View Erypo Review and Erypo Label ), FERRLECIT (120 Mg Per Week) (View Ferrlecit Review and Ferrlecit Label ), VANCOMYCIN HCL (1 G Per Week) (View Vancomycin Hcl Review and Vancomycin Hcl Label ), OXAZEPAM (7-10 Mg Per Week By Family Doctor) (View Oxazepam Review and Oxazepam Label ), TORASEMID (15 Mg Daily By Family Doctor) (View Torasemid Review and Torasemid Label ), SIMVASTATIN (7- 20 Mg Per Week By Family Doctor) (View Simvastatin Review and Simvastatin Label ), DOMINAL FORTE (80 Mg Daily By Family Doctor) (View Dominal Forte Review and Dominal Forte Label ), MIRTAZAPIN (15 Mg Daily By Family Doctor) (View Mirtazapin Review and Mirtazapin Label ).

6965720-3 | Transplant
Adverse event was reported on Aug 30, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GERMANY , 54 years of age, weighting 132.3 lb, After Zemplar was administered, patient had the following side effects: transplant. During the same period patient was treated with DEKRISTOL (20000 Ie) (View Dekristol Review and Dekristol Label ), RENAGEL (Am 1 Tablet, Noon 2; Evening 2) (View Renagel Review and Renagel Label ), CALCET (Noon, Evening) (View Calcet Review and Calcet Label ), ARANESP (One Pre Filled Syrige Every Other Week) (View Aranesp Review and Aranesp Label ), ALLOPURINOL HEXAL (Opd, 1/2 Tablet In Evening) (View Allopurinol Hexal Review and Allopurinol Hexal Label ), DREISAVIT N (Opd, Morning) (View Dreisavit N Review and Dreisavit N Label ), NOVALGIN (If Required) (View Novalgin Review and Novalgin Label ). Patient was hospitalized.

6964541-5 | Pneumonia
on Aug 27, 2010 Male patient from GERMANY , 70 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Zemplar dosage: . During the same period patient was treated with CALCITRIOL (6 Capsules On Mondays After Dialysis) (View Calcitriol Review and Calcitriol Label ), CINACALCET HYDROCHLORIDE (Evening Opd On Dialysis Day) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), CALCIUMACETAT (Morning , Noon,evening) (View Calciumacetat Review and Calciumacetat Label ), RENAGEL (View Renagel Review and Renagel Label ), FERRLECIT (View Ferrlecit Review and Ferrlecit Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID FORTE (View Folic Acid Forte Review and Folic Acid Forte Label ), CARENAL (Non) (View Carenal Review and Carenal Label ). Patient was hospitalized.

6963843-6 | Abdominal Wall Abscess
on Aug 26, 2010 Female patient from GERMANY , 58 years of age, was treated with Zemplar (View Usage). Patient had the following side effects: abdominal wall abscess. Zemplar dosage: . Patient was hospitalized.

6963537-7 | Vascular Resistance Systemic
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: vascular resistance systemic on Aug 30, 2010 from GERMANY Additional patient health information: Female patient , 56 years of age, weighting 134.5 lb, was diagnosed with hyperparathyroidism secondary and. Zemplar dosage: 28 Mcg Weekly. During the same period patient was treated with CHOLECALCIFEROL (1000 Ie Per Week) (View Cholecalciferol Review and Cholecalciferol Label ), NIMPARA (630 Mg Per Week) (View Nimpara Review and Nimpara Label ), RENAGEL (4800 Mg) (View Renagel Review and Renagel Label ), ERYPO (12000ie Per Week) (View Erypo Review and Erypo Label ). Patient was hospitalized.

6961668-9 | Toe Amputation
Adverse event was reported on Aug 27, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GERMANY , 72 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: toe amputation. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), DECORTIN H (View Decortin-h Review and Decortin-h Label ), PLAVIX (View Plavix Review and Plavix Label ), LOCOL (View Locol Review and Locol Label ), ENALAPRIL (2.5 Mg At The Day Free Of Dialysis) (View Enalapril Review and Enalapril Label ), CORDAREX (1 Tab Od Except For Saturday And Sunday) (View Cordarex Review and Cordarex Label ), DOXAZOSIN URO (View Doxazosin Uro Review and Doxazosin Uro Label ). Patient was hospitalized.

6961080-2 | Cardiac Failure, Hypertension, Implantable Defibrillator Insertion
on Mar 17, 2007 Male patient from GERMANY , weighting 173.1 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease (What is coronary artery disease?), blood phosphorus increased, peripheral arterial occlusive disease and was treated with Zemplar (View Usage). Patient had the following side effects: cardiac failure, hypertension, implantable defibrillator insertion. Zemplar dosage: . During the same period patient was treated with ISMO (View Ismo Review and Ismo Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ANTIPHOSPHATE (View Antiphosphate Review and Antiphosphate Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6959070-9 | Colitis, Hospitalisation
on Aug 27, 2010 Female patient from GERMANY , 88 years of age, weighting 143.3 lb, was diagnosed with dialysis (What is dialysis?), hyperparathyroidism and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: colitis, hospitalisation. Zemplar dosage: . During the same period patient was treated with RETRACIT 2000 (2000ie) (View Retracit 2000 Review and Retracit 2000 Label ), FERRLECIT (View Ferrlecit Review and Ferrlecit Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARENAL (View Carenal Review and Carenal Label ), CARMEN (View Carmen Review and Carmen Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6956272-2 | Colitis
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: colitis on Aug 20, 2010 from GERMANY Additional patient health information: Female patient , 86 years of age, weighting 153.2 lb, was diagnosed with hyperparathyroidism, iron deficiency, platelet aggregation inhibition, mineral supplementation, hypertension, hypercholesterolaemia and. Zemplar dosage: . During the same period patient was treated with RETACRIT (View Retacrit Review and Retacrit Label ), FERRLECIT (View Ferrlecit Review and Ferrlecit Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARENAL (View Carenal Review and Carenal Label ), CARMEN (View Carmen Review and Carmen Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6955102-2 | Ileal Operation, Ileostomy
Adverse event was reported on Aug 23, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) . Location: GERMANY , 44 years of age, Patient had the following side effects: ileal operation, ileostomy. Patient was hospitalized.

6946159-3 | Transplant
on Aug 18, 2010 Female patient from GERMANY , 54 years of age, weighting 132.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: transplant. Zemplar dosage: . During the same period patient was treated with DEKRISTOL (20000 Ie) (View Dekristol Review and Dekristol Label ), RENAGEL (Am 1 Tablet, Noon 2; Evening 2) (View Renagel Review and Renagel Label ), CALCET (Noon, Evening) (View Calcet Review and Calcet Label ), ARANESP (One Pre Filled Syrige Every Other Week) (View Aranesp Review and Aranesp Label ), ALLOPURINOL HEXAL (Opd, 1/2 Tablet In Evening) (View Allopurinol Hexal Review and Allopurinol Hexal Label ), DREISAVIT N (Opd, Morning) (View Dreisavit N Review and Dreisavit N Label ), NOVALGIN (If Required) (View Novalgin Review and Novalgin Label ). Patient was hospitalized.

6943393-3 | Humerus Fracture, Radius Fracture, Retroperitoneal Haematoma, Rib Fracture, Ulna Fracture
on Aug 19, 2010 Female patient from AUSTRIA , 57 years of age, weighting 196.2 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: humerus fracture, radius fracture, retroperitoneal haematoma, rib fracture, ulna fracture. Zemplar dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LASIX (View Lasix Review and Lasix Label ), NOVOMIX (View Novomix Review and Novomix Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), DIGIMERCK (View Digimerck Review and Digimerck Label ), ACEMIN (View Acemin Review and Acemin Label ), CONCOR (View Concor Review and Concor Label ), FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

6941459-5 | Hypertensive Crisis, Sinus Tachycardia
Patient was taking Zemplar (View Usage). Patient had the following side effects: hypertensive crisis, sinus tachycardia on Aug 19, 2010 from AUSTRIA Additional patient health information: Male patient , 28 years of age, weighting 87.96 lb, was diagnosed with hyperparathyroidism secondary, hypertension, gastritis and. Zemplar dosage: . During the same period patient was treated with RENAGEL (2-2-2) (View Renagel Review and Renagel Label ), DIOVAN (1-0-1) (View Diovan Review and Diovan Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6940592-1 | Gastric Haemorrhage, Melaena
Adverse event was reported on Aug 16, 2010 by a Male patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary, arteriosclerosis, hyperphosphataemia, anaemia, hypertriglyceridaemia, muscular dystrophy (What is muscular dystrophy?) and. Location: GREECE , 81 years of age, weighting 112.4 lb, After Zemplar was administered, patient had the following side effects: gastric haemorrhage, melaena. During the same period patient was treated with XEFO (View Xefo Review and Xefo Label ), VASTAREL (View Vastarel Review and Vastarel Label ), FORSENOL (750mg At Noon And 750mg In The Evening) (View Forsenol Review and Forsenol Label ), FILICINE (View Filicine Review and Filicine Label ), RENAGEL (3 Caps In Am, 3 At Noon And 3 In Pm) (View Renagel Review and Renagel Label ), LOPID (View Lopid Review and Lopid Label ), SUPERAMIN (View Superamin Review and Superamin Label ). Patient was hospitalized.

6936047-0 | Gastro-enterostomy, Ileal Operation
on Aug 13, 2010 Male patient from GERMANY , 44 years of age, was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: gastro-enterostomy, ileal operation. Zemplar dosage: . Patient was hospitalized.

6931272-7 | Aortic Valve Disease, Aortic Valve Disease Mixed, Blood Pressure Decreased, Chills, Coronary Artery Disease, Dyspnoea, Emphysema, Enterococcal Infection, Hypertension
on Aug 04, 2010 Male patient from GERMANY , 69 years of age, weighting 172.0 lb, was diagnosed with renal failure, hypertension, coronary artery disease (What is coronary artery disease?) and was treated with Zemplar (View Usage). Patient had the following side effects: aortic valve disease, aortic valve disease mixed, blood pressure decreased, chills, coronary artery disease (What is coronary artery disease?), dyspnoea, emphysema, enterococcal infection, hypertension. Zemplar dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PENTALONG 80 (View Pentalong 80 Review and Pentalong 80 Label ), MOLSIDOMIN (View Molsidomin Review and Molsidomin Label ), CARVEDILOL (2 Tablets Daily) (View Carvedilol Review and Carvedilol Label ), DIOVAN 160 (1 Tablet Daily) (View Diovan 160 Review and Diovan 160 Label ). Patient was hospitalized.

6930241-0 | Abdominal Distension, Abdominal Pain, Dizziness, Thirst, Vomiting
Patient was taking Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), dizziness (What is dizziness?), thirst, vomiting on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 186.0 lb, was diagnosed with blood test and. Zemplar dosage: 1 A - Day.

6926483-0 | Arteriosclerosis Obliterans, Erythema, Oedema Peripheral, Pain In Extremity, Pulse Absent
Adverse event was reported on Aug 06, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary, hypertension, pain (What is pain?), restless legs syndrome and. Location: GERMANY , weighting 202.8 lb, Patient experienced the following unwanted or unexpected effects: arteriosclerosis obliterans, erythema, oedema peripheral, pain in extremity, pulse absent. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), TORASEMID (View Torasemid Review and Torasemid Label ), OSVAREN (View Osvaren Review and Osvaren Label ), DREISAVIT N (View Dreisavit N Review and Dreisavit N Label ), BENAZEPRIL (View Benazepril Review and Benazepril Label ), FENTANYL PLASTER (Per Hour Every Three Days) (View Fentanyl Plaster Review and Fentanyl Plaster Label ), RESTEX (On Demand) (View Restex Review and Restex Label ), MARCUMAR (According To Target Inr 2-3) (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6922972-3 |
on Aug 05, 2010 Male patient from GERMANY , weighting 260.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). . Zemplar dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), CLOPIDOGREL (Opd) (View Clopidogrel Review and Clopidogrel Label ), VOCADO 20/5 (1 Tablet On Dialysis-free Day) (View Vocado 20/5 Review and Vocado 20/5 Label ), FUROSEMID (250 Mg Dft) (View Furosemid Review and Furosemid Label ), HCT (12.5 Mg Dft) (View Hct Review and Hct Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), CINACALCET HYDROCHLORIDE (Opd) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), RENVELA (View Renvela Review and Renvela Label ).

6888457-8 | Balance Disorder, Blood Magnesium Decreased, Blood Potassium Decreased, Hypotension, Syncope
on Jul 22, 2010 Male patient from UNITED STATES , weighting 225.2 lb, was diagnosed with renal disorder and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: balance disorder, blood magnesium decreased, blood potassium decreased, hypotension, syncope. Zemplar dosage: . Patient was hospitalized.

6884184-1 | Cardiac Failure Acute, Leukopenia, Metastatic Bronchial Carcinoma
Patient was taking Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute, leukopenia, metastatic bronchial carcinoma on Jul 21, 2010 from GERMANY Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary and. Zemplar dosage: 3x/wk Every 3 Weeks. During the same period patient was treated with DREISAVIT (1 Day) (View Dreisavit Review and Dreisavit Label ), DELIX (1 Day) (View Delix Review and Delix Label ), ASPIRIN (1 Day) (View Aspirin Review and Aspirin Label ), DIGIMERCK (1 Day) (View Digimerck Review and Digimerck Label ), LYRICA (2 Days) (View Lyrica Review and Lyrica Label ), FERRLECIT (2 Weeks) (View Ferrlecit Review and Ferrlecit Label ), PHOSPHATE BINDER (View Phosphate Binder Review and Phosphate Binder Label ).

6880894-0 | Erythema, Oedema Peripheral, Pain In Extremity, Skin Ulcer
Adverse event was reported on Jul 19, 2010 by a Female patient taking Zemplar (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary, hypertension, pain (What is pain?), restless legs syndrome and. Location: GERMANY , weighting 202.8 lb, Patient had the following side effects: erythema, oedema peripheral, pain in extremity, skin ulcer. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), OSVAREN (View Osvaren Review and Osvaren Label ), DREISAVIT N (View Dreisavit N Review and Dreisavit N Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), FENTANYL PLASTER (Per Hour Every Three Days) (View Fentanyl Plaster Review and Fentanyl Plaster Label ), RESTEX (On Demand) (View Restex Review and Restex Label ), MARCUMAR (According To Target Inr 2-3) (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6879245-7 | Cardiac Failure, Diabetic Foot
on Jul 19, 2010 Female patient from GERMANY , weighting 264.6 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar (View Usage). After Zemplar was administered, patient had the following side effects: cardiac failure, diabetic foot. Zemplar dosage: . During the same period patient was treated with TORSEMIDE (In Morning And At Noon) (View Torsemide Review and Torsemide Label ), CONCOR COR (In Morning And Evening) (View Concor Cor Review and Concor Cor Label ), ASPIRIN (In Morning) (View Aspirin Review and Aspirin Label ), OSRAREN (In Morning And Evening) (View Osraren Review and Osraren Label ), ZINKIT (In Evening) (View Zinkit Review and Zinkit Label ), LYRICA (In Evening) (View Lyrica Review and Lyrica Label ), LEVEMIR (According To Plan (44-0-30)) (View Levemir Review and Levemir Label ), NOVORAPID (According To Blood Glucose) (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6860973-4 | Cardiac Failure Acute, Leukopenia, Metastatic Bronchial Carcinoma
on Jul 15, 2010 Male patient from GERMANY , weighting 185.2 lb, was diagnosed with renal failure chronic and was treated with Zemplar (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute, leukopenia, metastatic bronchial carcinoma. Zemplar dosage: .

6848252-2 | Muscle Abscess, Staphylococcal Sepsis
Patient was taking Zemplar (View Usage). Patient had the following side effects: muscle abscess, staphylococcal sepsis on Jul 09, 2010 from AUSTRIA Additional patient health information: Male patient , weighting 203.9 lb, was diagnosed with hyperparathyroidism and. Zemplar dosage: . Patient was hospitalized.